LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation

被引:0
|
作者
Zhang, Heng [1 ,2 ]
Jian, Junling [1 ]
Chen, Hai [1 ]
Zhu, Xiaodong [1 ]
Xie, Jianfeng [1 ]
Xu, Xianquan [1 ]
机构
[1] Anhui Chest Hosp, Dept Thorac Surg, Hefei 230031, Anhui, Peoples R China
[2] Anhui Chest Hosp, Dept Thorac Surg, 397 Jixi Rd, Hefei 230022, Anhui, Peoples R China
关键词
NSCLC; LAGE3; AKT/PI3K; Cell proliferation; Migration and invasion; Stemness; EXPRESSION; DIAGNOSIS;
D O I
10.1016/j.prp.2023.154700
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Non-small cell lung cancer (NSCLC) is reported to have high mortality and morbidity rate worldwide. It is highly susceptible to metastasis. Previous reports have shown the L antigen family member 3 (LAGE3) expression in many cancers and has a carcinogenic role. However, the molecular mechanism of LAGE3 in NSCLC needs to be further explored.Methods: LAGE3 expression profile of NSCLC patients and normal samples in the TCGA cohort was utilized for visualization. Expression pattern of LAGE3 in cell lines of NSCLCs were determined through qRT-PCR. Further, transfection experiments was conducted to measure the LAGE3 & PRIME;s effect on the migration, proliferation, invasion, and stemness in NSCLC cell lines (A549 and H1975) by the assays of CCK-8, colony formation, EdU, transwell, and flow cytometry. The in vivo xenograft tumor growth in the nude mouse was conducted to confirm LAGE3 effect on NSCLC tumor growth. Furthermore, western blotting was applied to determine the levels of core proteins including AKT/PI3K signaling pathway and stemness proteins of Nanog, OCT4 and SOX2.Results: The TCGA based computational analysis showed that LAGE3 mRNA level in NSCLC was inter-related to worse overall survival. The up-regulated level of LAGE3 in NSCLC cell lines indicated its possibility as a future diagnostic and prognostic biomarker. Functional assays showed that cell migration, proliferation, invasion, sphere formation, and stemness-related protein (Nanog, SOX2, and OCT4) levels were significantly repressed by the knockdown of LAGE3. Subsequently, inhibition of LAGE3 in nude mice (in vivo) demonstrated its ability to reduce the tumor growth of NSCLC. The study also showed that LAGE3 knockdown suppressed cell progression by inactivating the signaling pathway of AKT/PI3K. Conclusions: LAGE3 could promote NSCLC development by activating the AKT/PI3K signaling pathway, thereby accelerating metastasis and cell stemness.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
    Wu, Dong-ming
    Zhang, Ting
    Liu, Ya-bin
    Deng, Shi-hua
    Han, Rong
    Liu, Teng
    Li, Jing
    Xu, Ying
    CELL DEATH & DISEASE, 2019, 10 (5)
  • [42] Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway
    Yang, Fan
    Zheng, Yunfeng
    Luo, Qiong
    Zhang, Suyun
    Yang, Sheng
    Chen, Xiangqi
    BMC CANCER, 2024, 24 (01)
  • [43] Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway
    Fan Yang
    Yunfeng Zheng
    Qiong Luo
    Suyun Zhang
    Sheng Yang
    Xiangqi Chen
    BMC Cancer, 24
  • [44] UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway
    Gu, Yong-Fei
    Ge, Xing-Ping
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (05) : 970 - 975
  • [45] Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
    Liu, Fujuan
    Liu, Tao
    Li, Haiying
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [46] Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
    Fujuan Liu
    Tao Liu
    Haiying Li
    Cancer Cell International, 21
  • [47] Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
    Jin, Ying
    Chen, Yamei
    Tang, Huarong
    Hu, Xiao
    Hubert, Shawna M.
    Li, Qian
    Su, Dan
    Xu, Haimiao
    Fan, Yun
    Yu, Xinmin
    Chen, Qixun
    Liu, Jinshi
    Hong, Wei
    Xu, Yujin
    Deng, Huan
    Zhu, Dapeng
    Li, Pansong
    Gong, Yuhua
    Xia, Xuefeng
    Gay, Carl M.
    Zhang, Jianjun
    Chen, Ming
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 526 - 539
  • [48] Dieckol inhibits non-small-cell lung cancer cell proliferation and migration by regulating the PI3K/AKT signaling pathway
    Wang, Chun-Hong
    Li, Xiao-Feng
    Jin, Li-Fang
    Zhao, Yan
    Zhu, Geng-Jun
    Shen, Wei-Zhang
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2019, 33 (08)
  • [49] Diprophylline inhibits non-small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway
    Zhao, Hong-Ying
    Ren, Yun-Hui
    Ren, Xiu-Bao
    Wang, Yu
    ONCOLOGY LETTERS, 2019, 17 (01) : 857 - 862
  • [50] PTEN and PI3K/AKT in non-small-cell lung cancer
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Angel Molina, Miguel
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    PHARMACOGENOMICS, 2015, 16 (16) : 1843 - 1862